Phase 2 Autoimmune Diabetes Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Not Yet Recruiting
Phase 2
A Phase 2, Multicentre, Open-Label Study to Evaluate the Efficacy, Safety, and Beta-Cell Preserving Effects of MTF-3110 in Adults with Latent Autoimmune Diabetes in Adults (LADA)
Latent Autoimmune Diabetes
MTF Australia Pty Ltd120 enrolled1 locationACTRN12626000382370
Recruiting
Phase 2
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
Diabetes Mellitus, Type 1Diabetes type1Autoimmune Diabetes
Massachusetts General Hospital150 enrolled1 locationNCT05180591
Recruiting
Phase 2
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
Diabetes MellitusType 1 DiabetesDiabetes type1+1 more
Massachusetts General Hospital100 enrolled1 locationNCT05866536